Drug intelligence / Profile preview

tisseel

Development stage
Approved
Lead developer
Baxter
Modality
Recombinant Proteins and Enzymes, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

Tisseel is a fibrin sealant used as a topical hemostatic agent and surgical tissue adhesive. It contains two main active components—human fibrinogen and human thrombin—which, when mixed at the time of application, mimic the final step of the coagulation cascade to form a stable fibrin clot. This clot adheres to tissue surfaces, achieving hemostasis (control of bleeding) and sealing tissues. The formulation also includes synthetic aprotinin to increase resistance of the clot to degradation in environments with high fibrinolytic activity. Tisseel is indicated for use as an adjunct to hemostasis in adult and pediatric patients (>1 month old) undergoing surgery when conventional techniques are ineffective or impractical, including in patients on anticoagulation therapy. It is also indicated for sealing colonic anastomoses following reversal of temporary colostomies[1][2][3][4][5][6][7][8]. Developed by Baxter Healthcare, it has been approved since 1998.

Brand names
Tisseel
Other names
Tisseel Fibrin Sealantfibrin sealant (Tisseel)
02

Targets

Plasmin and other fibrinolytic proteasesF2 (Thrombin)

Beyond the preview

Go deeper on tisseel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tisseel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call